192 related articles for article (PubMed ID: 29286619)
1. Comparison of Diagnostic Yield of a FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases.
Ashok V; Ranganathan R; Chander S; Damodar S; Bhat S; S NK; A SK; Jadav SS; Rajashekaraiah M; T S S
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3457-3464. PubMed ID: 29286619
[TBL] [Abstract][Full Text] [Related]
2. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
[TBL] [Abstract][Full Text] [Related]
3. [Value of a Panel Fluorescence in Situ Hybridization in Three Kinds of Hematological Malignancies].
Qin YW; Wang XR; Yang YN; Wang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1289-1293. PubMed ID: 27784344
[TBL] [Abstract][Full Text] [Related]
4. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.
Van Limbergen H; Poppe B; Michaux L; Herens C; Brown J; Noens L; Berneman Z; De Bock R; De Paepe A; Speleman F
Genes Chromosomes Cancer; 2002 Jan; 33(1):60-72. PubMed ID: 11746988
[TBL] [Abstract][Full Text] [Related]
5. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
[TBL] [Abstract][Full Text] [Related]
6. Metaphase harvest and cytogenetic analysis of malignant hematological specimens.
Dal Cin P; McLaughlin C
Curr Protoc Hum Genet; 2012 Apr; Chapter 10():Unit 10.2.1-15. PubMed ID: 22470141
[TBL] [Abstract][Full Text] [Related]
7. Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
Cherry AM; Slovak ML; Campbell LJ; Chun K; Eclache V; Haase D; Haferlach C; Hildebrandt B; Iqbal AM; Jhanwar SC; Ohyashiki K; Sole F; Vandenberghe P; VanDyke DL; Zhang Y; Dewald GW
Leuk Res; 2012 Jul; 36(7):832-40. PubMed ID: 22537394
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
[TBL] [Abstract][Full Text] [Related]
9. FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia.
Dubuc AM; Davids MS; Pulluqi M; Pulluqi O; Hoang K; Hernandez-Sánchez JM; Schlich C; Hernández-Rivas JM; Brown JR; Dal Cin P
Am J Hematol; 2016 Oct; 91(10):978-83. PubMed ID: 27341486
[TBL] [Abstract][Full Text] [Related]
10. Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes.
He R; Wiktor AE; Durnick DK; Kurtin PJ; Van Dyke DL; Tefferi A; Patnaik MS; Ketterling RP; Hanson CA
Am J Clin Pathol; 2016 Jul; 146(1):86-94. PubMed ID: 27353768
[TBL] [Abstract][Full Text] [Related]
11. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Tansatit M
Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic characteristics of B cell chronic lymphocytic leukemia in 275 Chinese patients by fluorescence in situ hybridization: a multicenter study.
Lai YY; Huang XJ
Chin Med J (Engl); 2011 Aug; 124(16):2417-22. PubMed ID: 21933580
[TBL] [Abstract][Full Text] [Related]
13. Analytical and clinical performance of chromosomal microarrays compared with FISH panel and conventional karyotyping in patients with chronic lymphocytic leukemia.
Tang Z; Kanagal-Shamanna R; Tang G; Patel K; Medeiros LJ; Toruner GA
Leuk Res; 2021 Sep; 108():106616. PubMed ID: 34022744
[TBL] [Abstract][Full Text] [Related]
14. [Fluorescent in situ hybridization with a panel of probes detects molecular cytogenetic abnormalities in patients with chronic lymphocytic leukemia].
Xu W; Li JY; Li L; Yu H; Shen QD; Fan L; Qiao C; Hong M; Qian SX; Qiu HX
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2537-40. PubMed ID: 19080644
[TBL] [Abstract][Full Text] [Related]
15. Role of cytogenetic abnormalities detected by fluorescence
Shetty D; Jain H; Rohil Y; Khattry N; Sengar M; Bagal B; Jain H; Gokarn A; Punatar S; Avinash Bonda VN; Subramanian PG
Indian J Med Res; 2021 Apr; 153(4):475-483. PubMed ID: 34380794
[TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
17. Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics.
Konialis C; Savola S; Karapanou S; Markaki A; Karabela M; Polychronopoulou S; Ampatzidou M; Voulgarelis M; Viniou NA; Variami E; Koumarianou A; Zoi K; Hagnefelt B; Schouten JP; Pangalos C
Hematology; 2014 Jun; 19(4):217-24. PubMed ID: 23928116
[TBL] [Abstract][Full Text] [Related]
18. A retrospective analysis of cytogenetic and clinical characteristics in patients with multiple myeloma.
He J; Yang L; Meng X; Wei G; Wu W; Han X; Zheng G; Zheng W; Ye X; Shi J; Xie W; Zhang J; Huang H; Lin M; Cai Z
Am J Med Sci; 2013 Feb; 345(2):88-93. PubMed ID: 22986611
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma.
Gao X; Li C; Zhang R; Yang R; Qu X; Qiu H; Xu J; Lu H; Li J; Chen L
Med Oncol; 2012 Sep; 29(3):2200-6. PubMed ID: 21611837
[TBL] [Abstract][Full Text] [Related]
20. [Application of CD138 Immunomagnetic Sorting Myeloma Cells Combined with Fluorescence in Situ Hybridization for Detecting Cytogenetic Abnormalities of Multiple Myeloma].
Gao L; Liu Q; Shi Y; Dang H; He Q; Wang Z; Feng L; Li Y; Wang XY; Li N; Song WJ; Wang YL; Kong S; Lu J; Huang XJ; Lai YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):807-812. PubMed ID: 28641640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
